Atypical 11q deletions identified by array CGH may be missed by FISH panels for prognostic markers in chronic lymphocytic leukemia

被引：21

作者：

Gunn, S. R. ^{[1
,2
]}

Hibbard, M. K. ^{[3
]}

Ismail, S. H. ^{[2
]}

Lowery-Nordberg, M. ^{[4
]}

Mellink, C. H. M. ^{[5
]}

Bahler, D. W. ^{[6
,7
]}

Abruzzo, L. V. ^{[8
]}

Enriquez, E. L. ^{[1
]}

Gorre, M. E. ^{[1
]}

Mohammed, M. S. ^{[1
]}

Robetorye, R. S. ^{[2
]}

机构：

[1] Combimatrix Mol Diagnost, Irvine, CA USA

[2] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA

[3] Clarient Diagnost Lab, Aliso Viejo, CA USA

[4] Louisiana State Univ, Hlth Sci Ctr, Shreveport, LA 71105 USA

[5] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands

[6] Univ Utah, Dept Pathol, Salt Lake City, UT USA

[7] Univ Utah, ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA

[8] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA

来源：

LEUKEMIA | 2009年 / 23卷 / 05期

关键词：

COMPARATIVE GENOMIC HYBRIDIZATION; TUMOR-SUPPRESSOR; BREAST-CANCER; CLINICAL TOOL; PROTEIN PLZF; CELL-GROWTH; TSLC1; EXPRESSION; PROMOTER; SURVIVAL;

D O I：

10.1038/leu.2008.393

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1011 / 1017

页数：8

共 32 条

[1] Analysis of 11q21-24 loss of heterozygosity candidate target genes in breast cancer:: Indications of TSLC1 promoter hypermethylation [J].

Allinen, M ;

Peri, L ;

Kujala, S ;

Lahti-Domenici, J ;

Outila, K ;

Karppinen, SM ;

Launonen, V ;

Winqvist, R .

GENES CHROMOSOMES & CANCER, 2002, 34 (04) :384-389

[2] Unique gene expression and clinical characteristics are associated with the 11q23 deletion in chronic lymphocytic leukaemia [J].

Dickinson, JD ;

Smith, LM ;

Sanger, WG ;

Zhou, GM ;

Townley, P ;

Lynch, JC ;

Pavletic, ZS ;

Bierman, PJ ;

Joshi, SS .

BRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (04) :460-471

[3] Genomic aberrations and survival in chronic lymphocytic leukemia. [J].

Döhner, H ;

Stilgenbauer, S ;

Benner, A ;

Leupolt, E ;

Kröber, A ;

Bullinger, L ;

Döhner, K ;

Bentz, M ;

Lichter, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (26) :1910-1916

[4] Cryptic deletion involving the ATM locus at 11q22.3∼q23.1 in B-cell chronic lymphocytic leukemia and related disorders [J].

Eclache, V ;

Caulet-Maugendre, S ;

Poirel, HA ;

Djemai, M ;

Robert, J ;

Lejeune, F ;

Raphaël, M .

CANCER GENETICS AND CYTOGENETICS, 2004, 152 (01) :72-76

[5] Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer [J].

Fukuhara, H ;

Kuramochi, M ;

Fukami, T ;

Kasahara, K ;

Furuhata, N ;

Nobukuni, T ;

Maruyama, T ;

Isogai, K ;

Sekiya, T ;

Shuin, T ;

Kitamura, T ;

Reeves, RH ;

Murakami, Y .

JAPANESE JOURNAL OF CANCER RESEARCH, 2002, 93 (06) :605-609

[6]

Gao K, 2008, INT J ONCOL, V32, P1343

[7] Value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia [J].

Glassman, AB ;

Hayes, KJ .

CANCER GENETICS AND CYTOGENETICS, 2005, 158 (01) :88-91

[8] Loss of TSLC1 expression in lung adenocarcinoma: Relationships with histological subtypes, sex and prognostic significance [J].

Goto, A ;

Niki, T ;

Li, CP ;

Matsubara, D ;

Murakami, Y ;

Funata, N ;

Fukayama, M .

CANCER SCIENCE, 2005, 96 (08) :480-486

[9] Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia [J].

Gunn, Shelly R. ;

Mohammed, Mansoor S. ;

Gorre, Mercedes E. ;

Cotter, Philip D. ;

Kim, Jaeweon ;

Bahler, David W. ;

Preobrazhensky, Sergey N. ;

Higgins, Russell A. ;

Bolla, Aswani R. ;

Ismail, Sahar H. ;

de Jong, Daphne ;

Eldering, Eric ;

van Oers, Marinus H. J. ;

Mellink, Clemens H. M. ;

Keating, Michael J. ;

Schlette, Ellen J. ;

Abruzzo, Lynne V. ;

Robetorye, Ryan S. .

JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (05) :442-451

[10]

Gunn Shelly R, 2008, Expert Opin Med Diagn, V2, P731, DOI 10.1517/17530059.2.6.731

← 1 2 3 4 →